- 充值
- 帮助
Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors. Covers clinical and experimental research in oncology and hematology Focuses on experimental therapeutics in the field of immunotherapy and chemotherapy Coverage includes immunobiology, pathogenesis, and treatment of malignant tumors
vol.42 (2024)
vol.41 (2024)
vol.41 (2023)
vol.40 (2023)
vol.40 (2022)
vol.39 (2022)
vol.38 (2021)
vol.37 (2020)
vol.37 (2019)
vol.36 (2019)
vol.35 (2018)
vol.34 (2017)
vol.33 (2016)
vol.32 (2015)
vol.31 (2014)
vol.30 (2013)
vol.29 (2012)
vol.28 (2011)
vol.27 (2010)
vol.26 (2009)
vol.25 (2008)
vol.24 (2007)
vol.23 (2006)
vol.22 (2005)
vol.21 (2004)
vol.20 (2003)
vol.19 (2002)
vol.18 (2001)
vol.17 (2000)
vol.16 (1999)
vol.15 (1998)
vol.14 (1997)
vol.13 (1996)
vol.12 (1995)
vol.11 (1994)
vol.8 (1991)
vol.5 (1988)
不详
Xing, ZongruiMa, YongJiang, XiangyanQing, HuiguoWu, YuxiaChe, ShengfuGao, ZhongtiWang, KeshenWang, TaoHe, QichenLi, ZhigangZhao, BinLiu, WenboSun, HaonanYu, Zeyuan
Thomas, Michael E.Jie, EmilyKim, Austin M.Mayberry, Trenton G.Cowan, Braydon C.Luechtefeld, Harrison D.Wakefield, Mark R.Fang, Yujiang
Zhuang, ZiyeCao, QiangChi, Hao